Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioplastics01:27

Bioplastics

Bioplastics derived from microbial processes present a sustainable alternative to conventional petroleum-based plastics. Among these, polyhydroxyalkanoates (PHAs), particularly polyhydroxybutyrates (PHBs), have emerged as prominent candidates due to their biodegradability and biocompatibility. These polymers are synthesized by a variety of bacteria, such as Cupriavidus necator and Pseudomonas putida, which naturally accumulate PHAs as intracellular carbon and energy reserves, especially under...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nuisance and alarming bleeding do not correlate with on-treatment platelet reactivity.

Cardiovascular revascularization medicine : including molecular interventionsยท2013
Same author

Impact of drug-eluting stents on distal vessels.

Circulation. Cardiovascular interventionsยท2012
Same author

Safety and efficacy of everolimus-eluting stents versus paclitaxel-eluting stents in a diabetic population.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventionsยท2012
Same author

Clinical and silent stroke following aortic valve surgery and transcatheter aortic valve implantation.

Cardiovascular revascularization medicine : including molecular interventionsยท2012
Same author

Impact of lesion location on intravascular ultrasound findings and short-term and five-year long-term clinical outcome after percutaneous coronary intervention for saphenous vein graft lesions.

International journal of cardiologyยท2011
Same author

Fluoroscopy use and left anterior descending artery angiography to guide transapical access in patients with prior cardiac surgery.

Cardiovascular revascularization medicine : including molecular interventionsยท2011
Same journal

Role of Phenolic Nanocompounds in Inflammatory Disorders: Current View and Future Aspects.

Current pharmaceutical designยท2026
Same journal

Overcoming Physiological Barriers in Brain Tumor Therapy: Advances in Nanomedicine, Ultramolecular Pharmaceuticals, and Targeted Drug Delivery.

Current pharmaceutical designยท2026
Same journal

Breathing Life into Research: The Transformative Potential of Lung-on-a-Chip Technology.

Current pharmaceutical designยท2026
Same journal

Cross-Tissue Transcriptome-Wide Association Study Prioritizes Candidate Genes and Compound-Associated Signatures for Osteoarthritis.

Current pharmaceutical designยท2026
Same journal

Emerging Role of AI in Gastroenterology and Hepatology: Revolutionizing Medical Device-Assisted Diagnosis.

Current pharmaceutical designยท2026
Same journal

Nanostructured Lipid Carriers in Drug Targeting: Characterization, Patents, and Recent Innovations.

Current pharmaceutical designยท2026
See all related articles

Related Experiment Video

Updated: Jun 5, 2026

Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention
11:01

Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention

Published on: September 18, 2015

Biodegradable and bioabsorbable stents.

Ron Waksman1, Rajbabu Pakala

  • 1Washington Hospital Center 110 Irving Street, NW, Suite 4B-1 Washington, DC 20010, USA. ron.waksman@medstar.net

Current Pharmaceutical Design
|January 7, 2011
PubMed
Summary
This summary is machine-generated.

Biodegradable stents offer a promising alternative to traditional stents for treating atherosclerotic vascular disease, potentially reducing restenosis and improving drug delivery.

More Related Videos

Fabrication of Small Caliber Stent-grafts Using Electrospinning and Balloon Expandable Bare Metal Stents
06:55

Fabrication of Small Caliber Stent-grafts Using Electrospinning and Balloon Expandable Bare Metal Stents

Published on: October 26, 2016

Related Experiment Videos

Last Updated: Jun 5, 2026

Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention
11:01

Ferromagnetic Bare Metal Stent for Endothelial Cell Capture and Retention

Published on: September 18, 2015

Fabrication of Small Caliber Stent-grafts Using Electrospinning and Balloon Expandable Bare Metal Stents
06:55

Fabrication of Small Caliber Stent-grafts Using Electrospinning and Balloon Expandable Bare Metal Stents

Published on: October 26, 2016

Area of Science:

  • Biomaterials Science
  • Cardiovascular Medicine
  • Medical Device Engineering

Background:

  • Coronary angioplasty has advanced significantly for atherosclerotic vascular disease.
  • Drug-eluting stents, while effective, carry a risk of thrombogenic response.
  • In-stent restenosis remains a challenge in coronary interventions.

Purpose of the Study:

  • To review the potential of biodegradable stents as an alternative to permanent stents.
  • To explore the advantages of biodegradable stents in drug delivery and restenosis prevention.
  • To identify key characteristics and challenges for ideal biodegradable stent design.

Main Methods:

  • Review of current literature on biodegradable stent materials and performance.
  • Analysis of clinical trial data regarding feasibility and limitations.
  • Discussion of material properties, deployment, degradation, and biological response.

Main Results:

  • Biodegradable stents show promise in overcoming limitations of permanent stents.
  • Various materials like polyesters and polycarbonates are being investigated.
  • Challenges include ensuring reliable deployment, minimizing inflammation, and maintaining mechanical stability during degradation.

Conclusions:

  • Biodegradable stents represent a feasible advancement in treating coronary artery disease.
  • Further research is crucial to address inflammation and mechanical stability issues.
  • Optimized biodegradable stents could revolutionize treatment by offering improved drug delivery and reduced long-term complications.